Purification methods: A way to treat severe acute inflammation related to sepsis?

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Lukaszewicz, Anne Claire ^a   Payen, Didier ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

BLOOD PURIFICATION; CELL FUNCTION; CELLULAR IMMUNITY; DISEASE SEVERITY; FILTER; FLOW CYTOMETRY; FLUID RESUSCITATION; HEMOFILTRATION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL MONITORING; INFLAMMATION; MEDIATOR; NOTE; PATIENT SELECTION; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; SEPSIS; SEPTIC SHOCK; EXTRACORPOREAL CIRCULATION; IMMUNOLOGY; LEUKOCYTE; PHYSIOLOGY; PROCEDURES;

EXTRACORPOREAL CIRCULATION; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES; SEPSIS;

EID: 84879502055     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12757     Document Type: Note

References (15)

1. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009, 37:803-810. 10.1097/CCM.0b013e3181962316, 19237881.
2. Peng ZY, Wang HZ, Carter MJ, Dileo MV, Bishop JV, Zhou FH, Wen XY, Rimmelé T, Singbartl K, Federspiel WJ, Clermont G, Kellum JA. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int 2012, 81:363-369. 10.1038/ki.2011.320, 3269547, 21918497.
3. Rimmele T, Kellum JA. High-volume hemofiltration in the intensive care unit: a blood purification therapy. Anesthesiology 2012, 116:1377-1387. 10.1097/ALN.0b013e318256f0c0, 22534247.
4. Borthwick EM, Hill CJ, Rabindranath KS, Maxwell AP, McAuley DF, Blackwood B. High-volume haemofiltration for sepsis. Cochrane Database Syst Rev 2013, 1:CD008075.
5. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen D. Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med 2007, 35:2702-2708. 10.1097/01.CCM.0000295593.25106.C4, 18074472.
6. Gomez A, Wang R, Unruh H, Light R, Bose D, Chau T, Correa E, Mink S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990, 73:671-685. 10.1097/00000542-199010000-00013, 2221436.
7. Toft P, Schmidt R, Broechner AC, Nielsen BU, Bollen P, Olsen KE. Effect of plasmapheresis on the immune system in endotoxin-induced sepsis. Blood Purif 2008, 26:145-150. 10.1159/000113507, 18212497.
8. Ono S, Kimura A, Hiraki S, Takahata R, Tsujimoto H, Kinoshita M, Miyazaki H, Yamamoto J, Hase K, Saitoh D. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers. Surgery 2013, 153:262-271. 10.1016/j.surg.2012.06.023, 22884251.
9. Namas R, Zamora R, Namas R, An G, Doyle J, Dick TE, Jacono FJ, Androulakis IP, Nieman GF, Chang S, Billiar TR, Kellum JA, Angus DC, Vodovotz Y. Sepsis: Something old, something new, and a systems view. J Crit Care 2012, 27:314 e311-311. 3206132, 21798705.
10. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013, 13:260-268. 10.1016/S1473-3099(13)70001-X, 23427891.
11. Rimmelé T, Kaynar AM, McLaughlin JN, Bishop JV, Fedorchak MV, Chuasuwan A, Peng Z, Singbartl K, Frederick DR, Zhu L, Carter M, Federspiel WJ, Zeevi A, Kellum JA. Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study. Crit Care 2013, 17:R59. 10.1186/cc12587, 3672497, 23531333.
12. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, López MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, et al. A genomic storm in critically injured humans. J Exp Med 2011, 208:2581-2590. 10.1084/jem.20111354, 3244029, 22110166.
13. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605. 10.1001/jama.2011.1829, 3361243, 22187279.
14. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009, 35:678-686. 10.1007/s00134-008-1337-8, 2789433, 18946659.
15. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Monneret G. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 2004, 32:2329-2331.